A series of isolates of Streptococcus equi from the United States and Europe were compared by the bactericidal test, immunoblotting, DNA restrictions, and Southern hybridization analysis. All isolates tested were sensitive to the same bactericidal serum. In addition, immunoblotting revealed no differences in M proteins prepared by acid or mutanolysin extraction. Immunoblotting of acid extracts of the isolates with mucosal nasopharyngeal mucus from a convalescent horse revealed the presence of the 41,000-and 46,000-Mr polypeptide fragments of the M protein of S. èqui known to be important in stimulating mucosal nasopharyngeal immune responses. DNA restriction analysis of total cell DNA digests, as well as Southern hybridizations using an S. equi M protein gene probe, did not detect any differences among these isolates. Our results, therefore, confirm the antigenic homogeneity of the M proteins of S. equi isolates and suggest that variation in this antigen is not a reason for the failure of commercial vaccines in the field. Interestingly, the protoplast M proteins of all isolates showed remarkable size homogeneity, in contrast to the size variation reported in M proteins of group A streptococci.
Streptococcus equi causes strangles, a highly contagious disease of the upper respiratory tract and adjacent lymph nodes of horses and donkeys. Two antiphagocytic virulence factors have been identified on the surface of S. equi, the hyaluronic acid capsule and the M-like protein (2, 4, 16, 27) . In acid extracts, the protein is present in a series of defined fragments; the immunologically most reactive fragments have molecular weights of about 29,000, 41,000, and 46,000 (9, 26) . The determinant that elicits bactericidal (opsonic) antibodies is present on the 29,000-molecular-weight fragment (26) . The native M protein of S. equi is found as a trimer with molecular weights between 56,000 and 60,000 (9) .
Although protection against group A streptococcus infections in humans is associated with the presence of serum bactericidal antibodies (14) , these antibodies in horses correlate poorly with protection against S. equi (22) . Instead, studies in our laboratory have demonstrated that protection against strangles is correlated with the presence of mucosal nasopharyngeal immunoglobulin G and immunoglobulin A antibodies to acid-extracted M protein fragments with molecular weights of about 46,000 and 41,000 (8, 9) . Both bacterin and M protein extract-type vaccines have been widely used but have given disappointing results in the field (22) . These vaccines are effective in stimulating serum bactericidal antibodies but are ineffective in protecting horses against natural exposure either because of antigenic variations in the M protein or because they do not stimulate mucosal nasopharyngeal antibodies.
Unlike group A streptococci, for which at least 74 M types have been described (6), S. equi has only one M type, as precipitin analysis and passive protection studies in mice suggest (2, 16) . The only phenotypic variation reported has been matte-colony variants due to the presence of lysogenic bacteriophage that encodes or controls the production of hyaluronidase (24) . However, the presence of the phage does not affect the M protein of the host organism (25) .
In this paper, we describe the results of a comparison of a number of U.S. and European isolates of S. equi collected over a period of 10 years. Using sensitivity to a bactericidal serum, immunoblotting, DNA restriction analysis, and Southern hybridization with an S. equi M protein gene probe, we have been unable to detect any differences in the M proteins of the isolates, nor have we been able to detect differences either in the restriction endonuclease pattern of total cell DNA digests or in the size of the restriction fragments that carry the M protein gene. This finding is consistent with the conclusion that there is only one M type of S. equi.
MATERIALS AND METHODS
Organisms. S. equi isolates are described in Table 1 . Each isolate came from a different outbreak and was stored at -70°C in Todd-Hewitt broth (THB) immediately after isolation. For antigen preparation, cultures were grown at 370C in THB. Escherichia coli 1089 (lambda gtll/SEM7), carrying the S. equi M protein gene, has been described elsewhere (9) .
Bactericidal test. The sensitivity of 14 isolates of S. equi (Table 2) to a high-titer bactericidal serum was studied by using a modification of the tests described by Lancefield (12) for group A streptococci and by Timoney and Eggers (22) Samples (100 ,ul) of the blood-bacteria mixtures were removed at 120 min and diluted 1:10, 1:100, and 1:300 in THB. These dilutions were then drop plated (25 ,uI per drop) in triplicate on dry chocolate blood agar plates. Colony counts were performed following incubation at 37°C for 24 h.
Antigen preparations. The procedure of Lancefield and Perlmann (13) was used to prepare acid extracts of the S. equi cultures. Native M protein was obtained as described elsewhere (9) . Briefly, S. equi strains were grown overnight in 200 ml of THB, and cells were recovered by centrifugation at 7,000 x g for 15 min and washed twice with 20 mM (26) .
DNA restriction analysis. Total cell DNAs from S. equi strains were obtained as follows (9) . Cells were grown overnight in 200 ml of THB, recovered by centrifugation at 10,000 x g, and washed twice with TE buffer (10 mM Tris [pH 7.6], 1 mM EDTA). Cells were suspended in 2 ml of TE buffer containing 20 mg of lysozyme (Sigma) per ml and 50 ,ug of N-acetylmuramidase SG (Seikagaku Kogyo) per ml and were incubated at 37°C for 1 h. TE (1 ml) containing 10 mg of preincubated pronase was added, and the mixture was incubated for 30 min at 37°C. Cells were lysed with 1 ml of 20% SDS solution, adjusted to 50 mM NaCI, phenol extracted three times, chloroform extracted twice, and ether extracted several times. DNA (2 ,ug) of each strain was treated with 10 U of the appropriate enzyme in 50 ,ul of restriction buffer according to the instructions of the manufacturer (Bethesda Research Laboratories, Inc., Gaithersburg, Md., or Boehringer Mannheim Biochemicals, Indianapolis, Ind.). Electrophoresis of DNA was carried out in horizontal gels of 0.7% agarose in TBE buffer (89 mM Tris-borate, 89 mM boric acid, 0.5 mM EDTA) in a submarine unit (Hoefer HE99; Hoefer Scientific Instruments, San Francisco, Calif.) at 15.5 V/cm for 18 h. Gels were stained with ethidium bromide and visualized by illumination with long-wave UV light.
Southern hybridization. DNA digests were transferred from agarose gels to nitrocellulose membranes as described by Southern (19) . Cloned S. equi DNA fragments were isolated from low-temperature gel agarose (SeaPlaque; FMC Corp., Marine Colloids Div., Rockland, Maine) as described by Struhl (20) and were 32P labeled by nick translation. Hybridization was performed as described elsewhere (9) . RESULTS Sensitivity of S. equi strains to bactericidal serum. All isolates of S. equi were phagocytosed and killed in much greater numbers following treatment with the bactericidal serum (PP) than with the normal control serum (Table 2) . Counts (CFU) after 120 min were about 8 to 190 times higher for the normal serum than for the bactericidal serum.
Western blot (immunoblot) analysis. Blots of acid extracts from different S. equi isolates showed no differences when developed with nasopharyngeal mucus from a convalescent horse (Fig. 1 ). An acid extract of S. equi CF32, used to experimentally infect the horse from which convalescent nasopharyngeal mucus was obtained, showed no differences when compared with acid extracts of other isolates (Fig. 2) blots with antiserum to the M protein of S. equi CF32 (Fig.  3) . The 58,000-to 60,000-molecular-weight dimer of the native M protein was present in all strains analyzed. Larger bands, presumably the result of association of the M protein with other cell wall components (6, 9) , were also detected and were the same in all strains tested. Native M protein from CF32, the isolate used as a source of antigen for preparation of M protein antiserum, showed no differences when compared with native M proteins from other S. equi strains (Fig. 3) .
Blots developed with normal rabbit serum and with mucus from horses negative for antibodies to S. equi showed no reactivities with acid extracts and native M protein preparations (data not shown). Southern hybridization analysis. Southern blots ofHindIIIdigested total cell DNAs of several strains of S. equi probed with the [32P]dCTP-labeled EcoRI fragment of the recombinant phage lambda gtll/SEM7 that contained the M protein gene of S. equi (9) failed to detect any differences in the restriction patterns of all the strains tested (Fig. 5) . HindIII was selected because it cuts several times within the cloned fragment, thereby increasing the possibility of detecting restriction differences within that fragment among the different S. equi strains.
DISCUSSION
Strangles caused by S. equi continues to be one of the most serious bacterial diseases of horse populations throughout the world. Protection against the disease is more closely correlated with the presence of mucosal nasopharyngeal immunoglobulin G and immunoglobulin A antibodies to epitope(s) on acid hydrolytic M protein fragments with molecular weights of 41,000 and 46,000 than with serum bactericidal antibodies, as in the case of group A streptococcus infections in humans (7, 8, 12) . Commercial vaccine preparations consisting of heat-killed organisms or M protein-rich extracts seem to afford little protection, although they stimulate a good serum bactericidal response (22) . Our data suggest that vaccine failure is not likely due to variations in the M antigen.
Earlier precipitin and mouse passive protection studies have suggested that, unlike group A streptococcus, S. equi has only one serotype (2, 16) . Our studies using opsonization, Western blot, restriction endonuclease, and Southern blot analyses support this conclusion and confirm the antigenic homogeneity of S. equi isolates.
The bactericidal test commonly used by investigators working on the immune responses to streptococcal M proteins in fact measures an antibody that is opsonic. The term bactericidal became widely used because the assay of opsonic antibody is most conveniently and reliably performed in a system in which the antibody activity is measured by reduction in counts of viable streptococci following incubation with neutrophils in whole blood or in tissue culture medium. The traditional bactericidal assay is therefore a measure of the end result of both opsonizing activity and subsequent killing in neutrophils (11) . The assay used in our study compared the numbers of viable S. equi following treatment with a strongly bactericidal equine serum (PP) or a nonbactericidal serum pool free of S. equi antibody and subsequent incubation in horse blood for 120 min. Differences in counts between the two serum treatments for a strain of S. equi were taken as evidence of neutralization of the antiopsonic effect of the M protein of that strain by the type-specific antibody in the bactericidal serum. All of the strains in our study showed much lower counts after 120 min when pretreated with the bactericidal serum (PP) than when pretreated with the normal serum pool, suggesting that they all carried the same M protein antigen. This result was consistent with the findings of Bazeley (2), who demonstrated that antiserum produced against a single strain of S. equi protected mice against challenge by each of 32 strains of the organism in his collection. Two strains (e80-5 and V1331), however, in our study were phagocytosed and killed more effectively than the others. This result is unexplained but could be due to reduced amounts of M protein or capsular hyaluronic acid that resulted in greater phagocytosis of these strains. In addition, some strains may be more resistant to intracellular killing than others. However, studies to substantiate this have never been reported for group C streptococci.
The 46,000-and 41,000-Mr acid hydrolytic fragments of the M protein known to be important in stimulating mucosal nasopharyngeal immune responses were demonstrated in all the isolates tested (Fig. 1) . In addition, rabbit antiserum to the M protein of S. equi CF32 gave identical reactions with acid-extracted and protoplast M proteins of all the isolates surveyed ( Fig. 2 and 3 ). This finding is of great relevance to the potential success of vaccines that will stimulate local protective immune responses, such as the avirulent strain of S. equi developed in our laboratory (23) . This strain is protective in challenge studies and stimulates production of mucosal nasopharyngeal antibodies to the 41,000-and 46,000-Mr polypeptide fragments of the M protein of S. equi (23) . This or a similar vaccine therefore should be able to protect against most or all isolates of S. equi, since these polypeptide fragments are the same in S. equi isolates in the United States and Europe.
Restriction endonuclease analysis of total cell DNA has been very useful in epidemiological studies and in strain differentiation of several DNA and RNA viruses, as well as of bacteria (3, 14, 15, 17, 18) . By this technique, differences have been detected in strains of bacteria that were homogeneous by immunological analysis (21) . Our restriction endonuclease (Fig. 4) and Southern hybridization (Fig. 5) analyses, using two different restriction enzymes, failed to detect any differences among the isolates of S. equi and so corroborate the immunological findings. In contrast to S. equi, Streptococcus zooepidemicus, a closely related group C streptococcus, has been shown to possess different M pro- Of interest is the finding of remarkable size homogeneity in the protoplast M proteins of S. equi isolates (Fig. 3) (1, 5) . Examination of the nucleotide sequence of the cloned M protein gene (9) may offer some clues as to why the S. equi M protein is so antigenically stable and shows no size variation.
